News Menu

The latest weapon against cancer is … a keto diet?

image of mouse cancer cells
In mice with pancreatic and colorectal cancer, keto diets slow the growth of tumors, seen here in white, by a process called ferroptosis. This kills the cancer cells by causing a lethal buildup of toxic fatty molecules, stained red.

Dietitians say a keto diet could help you lose up to 10% of your body weight. These high-fat, low-carb meal plans trick the body into burning its own fat. They could also help fight a variety of cancers by starving tumors of the glucose they need to grow. On the surface, this seems ideal. But research suggests these diets may have a deadly, unintended side effect for cancer patients.

In mice with pancreatic and colorectal cancer, keto accelerates a lethal wasting disease called cachexia. Patients and mice with cachexia experience loss of appetite, extreme weight loss, fatigue, and immune suppression. The disease has no effective treatment and contributes to about 2 million deaths per year.

鈥淐achexia results from a wound that doesn鈥檛 heal,鈥 黑料吃瓜资源 (CSHL) Assistant Professor Tobias Janowitz says. 鈥淚t鈥檚 very common in patients with progressive cancer. They become so weak they can no longer handle anti-cancer treatment. Everyday tasks become Herculean labors.鈥

Janowitz and CSHL Postdoc Miriam Ferrer are working to divorce keto鈥檚 cancer-fighting benefits from its lethal side effect. They found pairing keto with common drugs called corticosteroids prevented cachexia in mice with cancer. Their tumors shrank and the mice lived longer.

鈥淗ealthy mice also lose weight on keto, but their metabolism adapts and they plateau,鈥 Janowitz explains. 鈥淢ice with cancer can鈥檛 adapt, because they can鈥檛 make enough of a hormone called corticosterone that helps regulate keto鈥檚 effects. They don鈥檛 stop losing weight.鈥

image of biological, physiological events of cachexia
While often studied as the end-state of a disease, researchers have found that cachexia is instead a cascading process. Biological systems gradually break down, causing a decline in whole-body health.

Keto causes toxic lipid byproducts to accumulate in and kill cancer cells by a process called ferroptosis. This slows tumor growth but also causes early-onset cachexia. When researchers replaced the depleted hormone with a corticosteroid, keto still shrank tumors but didn鈥檛 kickstart cachexia.

鈥淐ancer is a whole-body disease. It reprograms normal biological processes to help it grow,鈥 Ferrer says. 鈥淏ecause of this reprogramming, mice can鈥檛 use the nutrients from a keto diet, and waste away. But with the steroid, they did much better. They lived longer than with any other treatment we tried.鈥

Janowitz and Ferrer are part of an international effort taking on cancer cachexia. They recently published an of the condition. The team is now working to fine-tune corticosteroid timing and dosage to widen the window for effective cancer therapies in combination with keto.

鈥淲e want to push back against cancer even harder, so it grows slower still,鈥 Janowitz says. 鈥淚f we can broaden this effect, make the treatment more efficient, we can ultimately benefit patients and improve cancer therapeutics.鈥

Written by: Nick Wurm, Communications Specialist | [email protected] | 516-367-5940


Funding

鈥淟a Caixa鈥 Foundation, MRC Cancer Unit, Cancer Grand Challenges, Cancer Research UK, The Mark Foundation for Cancer Research, 黑料吃瓜资源, CSHL Cancer Center, National Institutes of Health, CK Hutchison Holdings Limited, University of Cambridge, The Atlantic Philanthropies, Medical Research Council

Citation

Ferrer, M., et al., 鈥淜etogenic diet promotes tumor ferroptosis but induces relative corticosterone deficiency that accelerates cachexia鈥, Cell Metabolism, June 12, 2023. DOI:  

Stay informed

Sign up for our newsletter to get the latest discoveries, upcoming events, videos, podcasts, and a news roundup delivered straight to your inbox every month.

  Newsletter Signup

Principal Investigator

Tobias Janowitz

Tobias Janowitz

Associate Professor
Cancer Center Program Co-Leader
M.D., Ph.D., University of Cambridge, UK, 2007

Tags